Columbus, OH, United States of America

Venkat Gopalan

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Message Pharmaceuticals, Inc.. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Venkat Gopalan. Retrieved from https://idiyas.com/inventor/venkat-gopalan-bvu6h5vp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Venkat Gopalan: Innovator in Antibacterial Research

Introduction

Venkat Gopalan is a notable inventor based in Columbus, OH (US). He has made significant contributions to the field of antibacterial research. His work focuses on the discovery of novel compounds that can combat bacterial infections.

Latest Patents

Venkat Gopalan holds a patent for "Bacterial RNase P proteins and their use in identifying antibacterial compounds." This invention features novel RNase P molecules and nucleic acids encoding the same. It also includes methods for the discovery of antimicrobial compounds, showcasing his innovative approach to addressing bacterial resistance.

Career Highlights

Gopalan is associated with Message Pharmaceuticals, Inc., where he continues to advance his research. His work has the potential to lead to significant breakthroughs in the development of new antibacterial therapies.

Collaborations

He collaborates with esteemed colleagues such as Milan Jovanovic and Paul S Eder, contributing to a dynamic research environment.

Conclusion

Venkat Gopalan's innovative work in antibacterial research exemplifies the importance of scientific advancements in combating bacterial infections. His contributions are paving the way for future developments in antimicrobial therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…